![Ivan Hyep](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Hyep
No open positions remaining
Net worth: 2 M $ as of 30/09/2026
Profile
Mr. Ivan Hyep was previously employed as a Chief Financial Officer & Treasurer by Bicara Therapeutics, Inc., a Finance Director by MOMA Therapeutics, Inc., and a Finance Manager by Bain Capital LP.
He received his undergraduate degree from Bentley University and an MBA from Questrom School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/08/2026 | 129,855 ( 0.2% ) | 2 M $ | 30/09/2026 |
Former positions of Ivan Hyep
| Companies | Position | End |
|---|---|---|
| BICARA THERAPEUTICS INC. | Director of Finance/CFO | 12/08/2026 |
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for regenerative medicine employing injectable gel-based scaffolds | Director of Finance/CFO | 01/03/2021 |
Bain Capital LP
 Bain Capital LP Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 10/01/2016 |
Education of Ivan Hyep
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Provides investment services | Finance |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Questrom School of Business
 Questrom School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MOMA Therapeutics, Inc.
MOMA Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for regenerative medicine employing injectable gel-based scaffolds | Health Technology |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
- Stock Market
- Insiders
- Ivan Hyep
